Diatreme Resources (ASX:DRX) is an emerging Australian producer of mineral and silica sands based in Brisbane. Our key projects comprise the Northern Silica Project and Galalar Silica Sand Project in Far North Queensland, located next to the world's biggest silica sand mine at Cape Flattery.
Copyright 2024 – Finance News Network
Source: Finance News Network
13 Feb 2023 - Splitit Limited (ASX:SPT) CEO Nandan Sheth discusses the buy now, pay later sector, and Splitit's business model partnerships.
Read More16 May 2024 - Glenn Corrie, CEO of Hazer Group, speaks about their groundbreaking low-emission hydrogen and graphite production technology, recent achievements, and future plans for commercialization and global expansion.
Read More12 Oct 2022 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses revenue growth, the company's strategic placement to Macnica, changes to the share registry and the outlook ahead.
Read More02 Mar 2023 - Scott Kelly, RAM CEO Australia, provides an introduction to the RAM Essential Services Property Fund (ASX:REP), discussing geographical spread, yield, investment strategy, financials and inflation.
Read More27 Aug 2024 - Lithium Universe Limited (ASX:LU7) CEO Alex Hanly provides an update on the company, discussing collaboration with the W8banaki, listing on the Frankfurt stock exchange and the OTC Markets and outlook.
Read More27 Oct 2022 - icetana Limited (ASX:ICE) CEO and Managing Director Matt Macfarlane discusses the company's recent deal with Japanese group Macnica and the launch of a new product.
Read More29 July 2025 - Sovereign Advisors Principal Advisor Zaheer Lalani and Investment Manager Max Riaz provide a quarterly update on the markets.
Read More30 Jul 2024 - Brendan Bradley - Managing Director - DevEx Resources (ASX:DEV) is an exploration company with a diversified portfolio of high-quality projects spanning some of Australia’s best endowed mining regions.
Read More19 Feb 2020 - BluGlass (ASX:BLG) Managing Director, Giles Bourne talks about the opportunities that laser diodes represent for the company, following the Photonics West Conference.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More
